Lululab AI Skin Medical Platform, Full-Scale Entry into Vietnam
AI beauty and healthcare company Lululab's AI skin medical platform has begun its full-scale entry into the global market, starting with Vietnam.
On the 6th, at the opening ceremony of the general hospital under Hanoi Medical University held in Hanoi, Vietnam, Choi Yong-jun, CEO of Lululab (sixth from the left), and other event officials are taking a commemorative photo.
[Photo by Lululab]
On the 6th, Lululab announced on the 7th that it had introduced the ‘LUMINI Kiosk’ and a hospital management customer relationship management (CRM) system at a general hospital affiliated with Hanoi Medical University.
Lululab's AI skin medical platform is an integrated system that includes an AI skin analysis solution that analyzes items necessary for dermatological treatment regardless of race or country worldwide, an optimized CRM for medical staff, and an application (app) that allows customers to track their own skin data. The LUMINI Kiosk, introduced for the first time in Vietnam, is linked with the CRM system, automatically database-optimizing skin analysis results and procedure information.
A Lululab official said, “Ultimately, the application used by patients will be linked with the AI skin analysis solution (kiosk) and CRM within the dermatology department,” adding, “Our ‘AI skin medical platform’ is scheduled to be supplied throughout Vietnam, starting with this general hospital introduction.”
The introduction of Lululab’s ‘AI skin medical platform’ is part of an agreement signed with Hanoi Medical University. In July last year, the two institutions signed a memorandum of understanding (MOU) on ‘joint research on the development of AI analysis solutions for skin diseases and the establishment of AI medical infrastructure in Vietnam.’ By introducing Lululab’s ‘AI medical platform’ into the medical network to be established based in major cities in Vietnam, they have been closely cooperating in research and nurturing talent in the medical AI field with the goal of building skin data of Southeast Asians and maximizing the commercial usability of AI solution services.
A company representative said, “Except for dermatology departments affiliated with general hospitals, officially licensed dermatology clinics are extremely rare in Vietnam, so most demand is met by general aesthetics or unlicensed clinics, creating a high need for an authorized dermatology market,” adding, “Vietnam is the country with the highest GDP growth rate in Asia, and as urbanization and industrialization rapidly grow the beauty market, we expect to commercially introduce the platform to more than 100 medical institutions within three years based on the hospital affiliated with Hanoi Medical University.”
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "I Will Give Them a Chance for Self-Examination": Chinese Scientific Community Shaken by Influencer's Preemptive Whistleblowing
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Meanwhile, Lululab has also started its medical AI platform business domestically. In May, it signed an MOU with Yonsei Cancer Hospital’s Scar Plastic Laser Center to strengthen cooperation and operation of the ‘Skin AI Research Center.’ By introducing AI skin analysis solutions and medical staff CRM systems within the center, it plans to operate an AI skin medical platform optimized for hospital environments from actual patient treatment to clinical research and expand its application to general hospitals and clinics in the future.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.